Novo Nordisk Launches Discounted Multi-Month Subscription Program for Wegovy via Telehealth Providers

on

Novo Nordisk announced a new multi-month subscription program for FDA-approved Wegovy (semaglutide) on March 31, 2026, offering eligible self-pay patients predictable monthly pricing through select telehealth providers like Ro, WeightWatchers, LifeMD, with Hims & Hers, Sesame, and others coming soon.123

Subscription options include 3-month ($329/month injection, $289/month pill), 6-month ($299/month injection, $269/month pill), and 12-month ($249/month for both), saving up to $1,200/year on injections and $600/year on pills.123

The program aims to reduce cost barriers, improve treatment adherence, and support long-term weight management for obesity patients.13

Separate limited-time offers exist for lower doses (e.g., $149/month for 1.5 mg and 4 mg self-pay, 4 mg rises to $199 after August 31, 2026); insured patients may access Wegovy for as low as $25/month via other programs.12

Sources:

1. https://www.prnewswire.com/news-releases/novo-nordisk-launches-first-and-only-multi-month-subscription-program-for-fda-approved-wegovy-offering-savings-of-up-to-1-200year-302729943.html

2. https://njbiz.com/novo-nordisk-wegovy-subscription-plan-savings/

3. https://www.pharmexec.com/view/novo-nordisk-launches-multi-month-subscription-program-wegovy